(Q43214398)

16 November 2017

title

EU conference 'The Microbial Threat'. (English)

1 reference

16 November 2017

3

1 reference

16 November 2017

Mevius DJ

1

1 reference

16 November 2017

Sprenger MJ

series ordinal

2

1 reference

16 November 2017

publication date

1 February 1999

1 reference

International Journal of Antimicrobial Agents

16 November 2017

published in

1 reference

16 November 2017

volume

11

1 reference

16 November 2017

issue

2

1 reference

16 November 2017

page(s)

101-105

1 reference

Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900093-4

7 January 2021

Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900093-4

7 January 2021

Use of antimicrobial agents and drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900093-4

7 January 2021

Emergence of multidrug-resistant Salmonella enterica serotype typhimurium DT104 infections in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900093-4

7 January 2021

Nosocomial infection caused by antibiotic-resistant organisms in the intensive-care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900093-4

7 January 2021

Antimicrobial-drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900093-4

7 January 2021

Epidemiology of drug resistance: implications for a post-antimicrobial era

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900093-4

7 January 2021

Methicillin-resistant Staphylococcus aureus in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900093-4

7 January 2021

Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900093-4

7 January 2021

Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900093-4

7 January 2021

Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900093-4

7 January 2021

The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900093-4

7 January 2021

Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900093-4

7 January 2021

Spread of plasmid-mediated nourseothricin resistance due to antibiotic use in animal husbandry

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900093-4

7 January 2021

Plasmid-borne streptothricin resistance in gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900093-4

7 January 2021

Optimizing antimicrobial therapy. A method for antimicrobial drug use evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900093-4

7 January 2021

Implementation of an educational program and an antibiotic order form to optimize quality of antimicrobial drug use in a department of internal medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900093-4

7 January 2021

Improving the quality of antimicrobial drug use can result in cost containment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900093-4

7 January 2021

The development of new antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900093-4

7 January 2021

10.1016/S0924-8579(98)00093-4

Identifiers

DOI

1 reference

16 November 2017

1 reference